terbinafine
Generic: TERBINAFINE HYDROCHLORIDE·Brand: LAMISIL, LAMISIL AT, TERBINAFINE HYDROCHLORIDE
terbinafine: sourced relationships with 1 company · 1 FDA decision.
terbinafine evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect terbinafine to NVS; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could terbinafine → NVS affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Uses cures most jock itch (tinea cruris) relieves itching, burning, cracking and scaling which accompany these conditions
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| Novartis AG (NVS) Reported 2007-09-28 · Current development: unknownSource Uses cures most jock itch (tinea cruris) relieves itching, b… | Approved |
| Novartis AG (NVS) Reported 2007-09-28 · Current development: unknownSource | Approved |
Frequently asked questions
Which companies have sourced relationships with terbinafine?
terbinafine has dated SEC/FDA relationship records for Novartis AG.
What is terbinafine's latest FDA decision?
The most recent tracked FDA decision for terbinafine is Approval, dated September 28, 2007.